Warhound emerges from stealth with $200 million for genetically enhanced military dogs

Warhound, a Texas defence technology company conceived by Anduril founder Palmer Luckey and Colossal Biosciences founder Ben Lamm, has emerged from stealth with a $200 million seed round to rebuild the US military working dog supply using advanced genetics and defence technology. The Financial Times reported the raise values the company at $1.2 billion. Investors include In-Q-Tel, Sequoia Capital, ARK Invest, Franklin Templeton, 8VC and Lux Capital. Warhound will license Colossal's genetics and cloning platform and equip dogs with Anduril's cybernetic Augments, eye and ear protection and Eagle Eye situational-awareness systems. The company says more than 80 percent of US military working dogs are acquired from Europe and fewer than half of procured dogs complete training. CEO David Spirk was the first chief data officer of the US Department of Defense and a senior counsellor at Palantir. The American Humane Society will guide and certify its training programmes; Luckey holds no equity and no day-to-day role.

DTT summary based on ThePrint's report. The full article is on the publisher's site.